Back
Foghorn Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
FHTX
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
50
FHTX
Foghorn Therapeutics
Last Price:
7.67
Seasonality Move:
18.5%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Foghorn Therapeutics Price Quote
$7.67
-0.34 (-4.24%)
(Updated: November 18, 2024 at 3:45 PM ET)
Foghorn Therapeutics Key Stats
Sell
50
Foghorn Therapeutics (FHTX)
is a Sell
Day range:
$7.33 - $8.79
52-week range:
$2.70 - $10.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.61
P/B ratio:
0%
Volume:
240.6K
Avg. volume:
128.6K
1-year change:
99.75%
Market cap:
$445.3M
Revenue:
$34.2M
EPS:
$-1.92
How Much Does Foghorn Therapeutics Make?
-
How Much Are Foghorn Therapeutics's Sales Annually?
FHTX Revenues are $34.2M -
How Much Profit Does Foghorn Therapeutics's Make A Year?
FHTX net income is -$98.4M
Is Foghorn Therapeutics Growing As A Company?
-
What Is Foghorn Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.55% -
What Is Foghorn Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Foghorn Therapeutics Stock Price Performance
-
Did Foghorn Therapeutics Stock Go Up Last Month?
Foghorn Therapeutics share price went up by 4.84% last month -
Did FHTX's Share Price Rise Over The Last Year?
FHTX share price rose by 99.75% over the past 1 year
What Is Foghorn Therapeutics 52-Week High & Low?
-
What Is Foghorn Therapeutics’s 52-Week High Share Price?
Foghorn Therapeutics has traded as high as $10.25 over the past 52 weeks -
What Is Foghorn Therapeutics’s 52-Week Low Share Price?
Foghorn Therapeutics has traded as low as $2.70 over the past 52 weeks
Foghorn Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Foghorn Therapeutics?
-
How Much Debt Does Foghorn Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Foghorn Therapeutics Have?
Cash and short term investments quarterly total is $267.4M -
What Is Foghorn Therapeutics’s Book Value Per Share?
Book value per share is -0.51
Is Foghorn Therapeutics Cash Flow Positive?
-
What Is FHTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$103.4M -
What Is Foghorn Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $105.6M -
What Is Foghorn Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$14.8M
Foghorn Therapeutics Return On Invested Capital
Data Unavailable
Foghorn Therapeutics Earnings Date & Stock Price
-
What Is Foghorn Therapeutics's Stock Price Today?
A single share of FHTX can be purchased today for 8.01 -
What Is Foghorn Therapeutics’s Stock Symbol?
Foghorn Therapeutics trades on the nasdaq under the ticker symbol: FHTX -
When Is Foghorn Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Foghorn Therapeutics is scheduled on May 6, 2025 -
When Is FHTX's next ex-dividend date?
Foghorn Therapeutics's next ex-dividend date is November 18, 2024 -
How To Buy Foghorn Therapeutics Stock?
You can buy Foghorn Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Foghorn Therapeutics Competitors
-
Who Are Foghorn Therapeutics's Competitors?
Below is a list of companies who compete with Foghorn Therapeutics or are related in some way:
Foghorn Therapeutics Dividend Yield
-
What Is FHTX Dividend Yield?
Foghorn Therapeutics’s dividend yield currently is 0% -
What Is Foghorn Therapeutics’s Payout Ratio?
Foghorn Therapeutics’s payout ratio is 0% -
When Did Foghorn Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is Foghorn Therapeutics’s Dividend Per Share?
Foghorn Therapeutics pays a dividend of $0.00 per share
Foghorn Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 27.91% |
Revenue: | -55.33% | 11.38% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 16.00 |
Upside from Last Price: | 99.75% |